Pharmaceutical Excipients Market Size to Cross USD 10.3 Billion by 2026

The Pharmaceutical Excipients market size is expected to be worth around Us$ 10.3 billion By 2026, With projected to the growth of 5.9% CAGR over the forecast time frame 2019-2026. In Pharmaceutical Excipients Market, The regional segmentation includes current and projected demand in North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.

Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1600

Some of the key observations regarding pharmaceutical excipients industry include:

In August 2019, LBB Specialties has entered into a partnership with MEGGLE Excipients & Technology to distribute MEGGLE's products in the U.S. nutraceutical and pharmaceutical markets. MeGGLE provides pharmaceutical-grade lactose to the world.
In July 2019, Colorcon announced its plan to open a starch manufacturing plant in the Netherlands. With the help of this new facility, Colorcon plans to double its existing manufacturing capacity by 2022. The location was strategically chosen in the Netherlands to become closer to the customer base in Europe.
In June 2019, Ideal Cures Pvt. Ltd., an India based manufacturer and exporter, expressed its interest to set up its first international manufacturing facility in the U.S. The company has distributors in more than 30 countries across the world and established its offices in Italy, Turkey, Israel, Spain, and the U.S. Ideal Cures is anticipated to open its manufacturing in the U.S. by April 2020. This will help the company to serve its existing customers and target new clients in the U.S.
In December 2018, Roquette purchased a majority stake in Crest Cellulose, a privately owned India based pharmaceutical excipients manufacturing company. With this transaction, Roquette expanded its cellulose based excipients and enhanced its capacity to serve customers in India and Asia.
In October 2017, Roquette opened a new Asia pacific headquarter and innovation center in Singapore. The new facility compliments Roquette's existing research in the field of food and pharmaceutical excipients. The facility will allow tailored company's products according to the dietary needs of the region.
In June 2017, Roquette acquired Itacel, a firm based in Brazil. Through this acquisition, Roquette entered into fast-growing Latin America market.
In October 2016, Ashland opened its pharmaceutical excipient production facility in China. The demand of excipients is continuously rising in China as the country's pharmaceutical industry moves to modern oral drug formulations. Hence, to serve better, Ashland opened a new facility in China.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/pharmaceutical-excipients-market

Pharmaceutical Excipients Market By Product (Organic Chemicals, Inorganic Chemicals, Others), By Function (Coating Agents, Fillers & Diluents, Suspending & Viscosity Agents, Binders, Flavoring Agents & Sweeteners, Disintegrants, Colorants, Emulsifying agents, Lubricants & Glidants, Preservatives, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

North America dominated the pharmaceutical excipients market in 2018. However, Asia Pacific is anticipated to propel the market growth with the fastest rate. Presence of pharmaceutical giants in the region, emphasis on high quality pharmaceutical products, and high consumption & demand for novel excipients are the key driving factors for the dominance of North America in the global market. The increasing number of pharmaceutical product manufacturers in the Asia Pacific region is expected to increase the demand for excipients in the coming years. Furthermore, extensive R&D in healthcare, rising disposable income, and increasing treatment rate are other factors to boost the pharmaceutical excipients market in Asia Pacific. Low cost raw materials and workforce and availability of resources for manufacturing facility are attracting several pharmaceutical companies in Asia Pacific. Japan, China, India, Singapore, and Australia are some of the major contributing countries in the region.

Based on the product, the pharmaceutical excipients are divided into organic chemicals, inorganic chemicals, and others. The organic chemicals segment dominated the pharmaceutical excipients market in 2018. This can be attributed to high demand from the pharmaceutical industry as organic chemicals such as proteins, carbohydrates, oleochemicals, and petrochemicals are majorly used in pharmaceutical formulations.

Related Reports

Biopharmaceutical Excipients Market - The global market is forecasted to grow with 6.9% CAGR between the year 2018 to 2025 and the biopharmaceutical excipients market is foreseen to reach USD 3.3 billion by 2026.
Pharmaceutical Cartridges Market - The global market size is anticipated to around USD 934.2 billion by 2026, this market is anticipated to grow with 8.0% CAGR during the forecast time period 2019 to 2026.
Active Pharmaceutical Ingredient (API) Market - The global market is forecasted to grow at a stable CAGR around 6.5% during the forecast period 2018 to 2026 and reach the market value around USD 260 billion by 2026.

On the basis of function, the market has been segmented into coating agents, filers & diluents, suspending & viscosity agents, binders, flavoring agents & sweeteners, disintegrants, colorants, emulsifying agents, lubricants & glidants, and preservatives. Fillers and diluents segment accounted for the maximum share of the market due to increased usage of fillers in the development and production of final formulations and advantages they offer.

Key operating players in the pharmaceutical excipients market are Archer Daniels Midland, Ashland, Akzo Nobel N.V., Associated British Foods Plc, BASF SE, Colorcon, Croda International, Dow Chemicals Corporation, DFE Pharma, Evonik, Innophos Holdings, J.M. Huber Corporation, Kerry Group Plc, Merck, and Merck Millipore. Collaboration with pharmaceutical companies, increasing manufacturing capacity, and strong distribution channels have been the most adopted strategies by industry players to enhance their market footprints.

Market Segmentation

Market By Product

Organic Chemicals

Oleochemicals
Carbohydrates
Petrochemicals
Proteins
Others

Inorganic Chemicals

Calcium Phosphate
Metal Oxides
Halites
Calcium Carbonate
Calcium Sulphate
Others

Others

By Function

Coating Agents
Fillers & Diluents
Suspending & Viscosity Agents
Binders
Flavoring Agents & Sweeteners
Disintegrants
Colorants
Emulsifying agents
Lubricants &Glidants
Preservatives
Others

By Geography

North America

US
Canada

Europe

UK
Germany
France
Spain
Rest of Europe

Asia-Pacific

China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Latin America

Brazil
Mexico
Rest of Latin America

Middle East & Africa

GCC
South Africa
Rest of Middle East & Africa

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

- What is the overall structure of the market?

- What was the historical value and what is the forecasted value of the market?

- What are the key product level trends in the market?

- What are the market level trends in the market?

- Which of the market players are leading and what are their key differential strategies to retain their stronghold?

- Which are the most lucrative regions in the market space?

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1600

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Pure Cashmere
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Pharmaceutical Excipients Market By Product
1.2.2.1. Global Pharmaceutical Excipients Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Pharmaceutical Excipients Market Revenue Share By Product in 2017
1.2.2.3. Organic Chemicals
1.2.2.3.1. Oleochemicals
1.2.2.3.2. Carbohydrates
1.2.2.3.3. Petrochemicals
1.2.2.3.4. Proteins
1.2.2.3.5. Others
1.2.2.4. Inorganic Chemicals
1.2.2.4.1. Calcium Phosphate
1.2.2.4.2. Metal Oxides
1.2.2.4.3. Halites
1.2.2.4.4. Calcium Carbonate
1.2.2.4.5. Calcium Sulphate
1.2.2.4.6. Others
1.2.2.5. Others
1.2.3. Pharmaceutical Excipients Market By Function
1.2.3.1. Global Pharmaceutical Excipients Market Revenue and Growth Rate Comparison By Function (2015-2026)
1.2.3.2. Global Pharmaceutical Excipients Market Revenue Share By Function in 2017
1.2.3.3. Coating Agents
1.2.3.4. Fillers & Diluents
1.2.3.5. Suspending & Viscosity Agents
1.2.3.6. Binders
1.2.3.7. Flavoring Agents & Sweeteners
1.2.3.8. Disintegrants
1.2.3.9. Colorants
1.2.3.10. Emulsifying agents
1.2.3.11. Lubricants &Glidants
1.2.3.12. Preservatives
1.2.3.13. Others
1.2.4. Pharmaceutical Excipients Market By Geography
1.2.4.1. Global Pharmaceutical Excipients Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Pharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Pharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Pharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Pharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Pharmaceutical Excipients Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Pure Cashmere Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Pure Cashmere Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Pure Cashmere Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Pure Cashmere Major Manufacturers in 2017

CHAPTER 4. PHARMACEUTICAL EXCIPIENTS MARKET BY PRODUCT
4.1. Global Pure Cashmere Revenue By Product
4.2. Organic Chemicals
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.2.1. Oleochemicals
4.2.2.2. Carbohydrates
4.2.2.3. Petrochemicals
4.2.2.4. Proteins
4.2.2.5. Others
4.3. Inorganic Chemicals
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.2.1. Calcium Phosphate
4.3.2.2. Metal Oxides
4.3.2.3. Halites
4.3.2.4. Calcium Carbonate
4.3.2.5. Calcium Sulphate
4.3.2.6. Others
4.4. Others

CHAPTER 5. PHARMACEUTICAL EXCIPIENTS MARKET BY FUNCTION
5.1. Global Pure Cashmere Revenue By Function
5.2. Coating Agents
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Fillers & Diluents
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Suspending & Viscosity Agents
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Binders
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Flavoring Agents & Sweeteners
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Disintegrants
5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.8. Colorants
5.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.9. Emulsifying agents
5.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.10. Lubricants &Glidants
5.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.11. Preservatives
5.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.12. Others

CHAPTER 6. NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY
6.1. North America Pharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Pharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Pharmaceutical Excipients Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE PHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY
7.1. Europe Pharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Pharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY
8.1. Asia-Pacific Pharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Pharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY
9.1. Latin America Pharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Pharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
9.4. Mexico
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET BY COUNTRY
10.1. Middle East & Africa Pharmaceutical Excipients Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East & Africa Pharmaceutical Excipients Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. GCC
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
10.4. South Africa
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)
10.5. Rest of Middle East & Africa
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Function, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE
11.1. Archer Daniels Midland
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Ashland
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Akzo Nobel N.V.
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Associated British Foods Plc
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. BASF SE
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Colorcon
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Croda International
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Dow Chemicals Corporation
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. DFE Pharma
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Evonik
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Others
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies

CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1600

If you would like to place an order or have any questions, please feel free to contact at [email protected] | +1-407-915-4157 OR +1-408-900-9135

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Contact Us:

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com

Follow Us: LinkedIN | Twitter